SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060253
Filing Date
2023-11-07
Accepted
2023-11-07 16:11:17
Documents
111
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnkd-20230930.htm   iXBRL 10-Q 3908903
2 EX-31.1 mnkd-ex31_1.htm EX-31.1 15512
3 EX-31.2 mnkd-ex31_2.htm EX-31.2 15491
4 EX-32.1 mnkd-ex32_1.htm EX-32.1 10555
5 EX-32.2 mnkd-ex32_2.htm EX-32.2 10546
  Complete submission text file 0000950170-23-060253.txt   16462390

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnkd-20230930.xsd EX-101.SCH 113305
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnkd-20230930_def.xml EX-101.DEF 489068
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnkd-20230930_pre.xml EX-101.PRE 677483
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnkd-20230930_cal.xml EX-101.CAL 89620
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnkd-20230930_lab.xml EX-101.LAB 760404
105 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20230930_htm.xml XML 3347397
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 231383833
SIC: 2834 Pharmaceutical Preparations